The Technical Analyst
Schrodinger Inc [SDGR]
Exchange: NASDAQ Sector: Healthcare Industry: Health Information Services
Schrodinger Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: SELL (auto-tracking)
-2.91% $23.34
America/New_York / 25 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 1 686.99 mill |
| EPS: | 0.540 |
| P/E: | 43.22 |
| Earnings Date: | May 01, 2024 |
| SharesOutstanding: | 72.28 mill |
| Avg Daily Volume: | 0.857 mill |
| RATING 2024-04-25 |
|---|
| B- |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Sell | |
| Return On Asset: | Sell | |
| DE: | Buy | |
| P/E: | Strong Sell | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 43.22 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE 43.22 | industry: PE -4.88 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$-22.85 (-197.88%) $-46.19 |
| Date: 2024-04-25 |
| Expected Trading Range (DAY) |
|---|
|
$ 21.94 - 24.74 ( +/- 6.02%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-03-21 | Abel Robert Lorne | Buy | 30 000 | Stock Option (right to buy) |
| 2024-03-21 | Lorton Kenneth Patrick | Buy | 30 000 | Stock Option (right to buy) |
| 2024-03-06 | Lorton Kenneth Patrick | Buy | 5 574 | Common Stock |
| 2024-03-06 | Lorton Kenneth Patrick | Sell | 5 574 | Stock Option (right to buy) |
| 2024-03-04 | Porges Geoffrey Craig | Buy | 90 000 | Stock Option (right to buy) |
| INSIDER POWER |
|---|
| 76.85 |
| Last 97 transactions |
| Buy: 2 214 027 | Sell: 335 407 |
Forecast:
16:00 - $23.36
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $23.36
Forecast 2: 16:00 - $23.36
Forecast 3: 16:00 - $23.36
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $23.34 (-2.91% ) |
| Volume | 0.898 mill |
| Avg. Vol. | 0.857 mill |
| % of Avg. Vol | 104.76 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For SDGR
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $27.19 | N/A | Active |
|---|
SDGR
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Last 10 Buy Signals
Latest Press Releases
2024-04-18 08:30:00 - Press Release
SchrÖdinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
New york--(business wire)--schrÖdinger today reported that on april 15, 2024, the company granted (i) non-statutory stock options and (ii) restricted stock units (rsus).
2024-04-10 08:30:00 - Press Release
SchrÖdinger To Announce First Quarter 2024 Financial Results On May 1
New york--(business wire)--schrÖdinger will report its first quarter 2024 financial results on wednesday, may 1, 2024, after the financial markets close.
2024-03-19 08:30:00 - Press Release
SchrÖdinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
New york--(business wire)--schrÖdinger today reported that on march 15, 2024, the company granted (i) non-statutory stock options and (ii) restricted stock units (rsus).
2024-02-16 08:30:00 - Press Release
SchrÖdinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
New york--(business wire)--schrÖdinger today reported that on february 13, 2024, the company granted (i) non-statutory stock options and (ii) restricted stock units (rsus).
2024-01-19 08:30:00 - Press Release
SchrÖdinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
New york--(business wire)--schrÖdinger today reported that on january 16, 2024, the company granted (i) non-statutory stock options and (ii) restricted stock units (rsus).
Latest News
2024-04-10 08:30:00 - Business Wire
Schrödinger to Announce First Quarter 2024 Financial Results on May 1
NEW YORK--(BUSINESS WIRE)--Schrödinger will report its first quarter 2024 financial results on Wednesday, May 1, 2024, after the financial markets close.
2024-04-02 16:30:04 - InvestorPlace
5 Healthcare Stocks to Buy for 2024
What has been the top-performing stock so far of 2024? If you had said server installer Super Micro Computer (NASDAQ: SMCI ), that would be a great answer.
2024-03-20 16:30:00 - InvestorPlace
Shhh! 7 Small-Cap Stocks That Can Double by 2025
Small cap stocks like those discussed below tend to receive much less attention than their large cap competitors. Shares, which boast a market capitalization between $250 million and $2 billion, remain relatively small.
2024-03-01 07:30:00 - InvestorPlace
The Hot List: 3 AI Stocks Worth Buying on Weakness
Wall Street has correctly recognized that artificial intelligence (AI) is a game-changer. It enables individuals to use computers more easily than ever before to find the best answers to complex questions.
2024-02-28 23:31:03 - Zacks Investment Research
Schrodinger, Inc. (SDGR) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Schrodinger, Inc. (SDGR) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
2024-02-28 18:55:19 - Zacks Investment Research
Schrodinger, Inc. (SDGR) Reports Q4 Loss, Misses Revenue Estimates
Schrodinger, Inc. (SDGR) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to loss of $0.39 per share a year ago.
2024-02-26 10:21:21 - Zacks Investment Research
Countdown to Schrodinger, Inc. (SDGR) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Besides Wall Street's top -and-bottom-line estimates for Schrodinger, Inc. (SDGR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
2024-02-19 17:13:12 - InvestorPlace
Double Your Money: 3 Growth Stocks to Grab in 2024
The near- and medium-term outlooks for growth stocks have greatly improved in recent weeks. That's because it appears that the Street has, at long last, realized that relatively small increases in interest rates don't necessarily portend doom for all growth names.
2023-12-11 08:01:45 - InvestorPlace
Artificial Intelligence in Healthcare: 3 Stocks Transforming the Industry
Artificial intelligence is being applied across the healthcare sector to improve delivery overall. AI stocks have the potential to impact stock sectors across the market positively, and healthcare is no different in that regard.
2023-11-14 00:06:35 - InvestorPlace
3 Cutting-Edge Biotech Stocks for the Bold Investor
Ahead of what could be significant uncertainties in the market, investors may be better served with cutting-edge biotech stocks. Fundamentally, the reasoning centers on relative insulation.